ArticleRMD open2022

Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort.

Joanna Kedra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.